Product Information
OSELTAMIVIR PHOS 45 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.8309 per EA under NDC 00527459213. Its NADAC has been published 126 times since Jan 31, 2024.
Strength
45 mg/1
Manufacturer
Lannett Company Inc.NDC
00527459213
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212739On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has been published 126 times since Jan 31, 2024, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8309 per EA |
|---|---|
| All-time high | $1.6332 (Feb 14, 2024) |
| All-time low | $0.8309 (Jun 17, 2026) |
| 52-week high | $1.1740 |
| 52-week low | $0.8309 |
| Median price | $1.1555 |
| Average price | $1.1941 |
| Largest weekly change | -30.3% (Apr 17, 2024) |
| Weeks tracked | 126 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 45 MG CAPSULE, manufactured by Lannett Company Inc., is $0.8309 per EA (NDC 00527459213), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has declined 49.1%. It has been tracked across 126 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 45 MG CAPSULE?
Since Jan 31, 2024, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has ranged from a low of $0.8309 (Jun 17, 2026) to a high of $1.6332 (Feb 14, 2024), with a median of $1.1555 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 45 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 45 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 45 MG CAPSULE?
OSELTAMIVIR PHOS 45 MG CAPSULE (NDC 00527459213) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification